Why Your Aesthetic Treatments Aren't Working: What Nobody Is Telling You
- Juvenology Clinic
- 1 day ago
- 10 min read
Regenerative aesthetics, polynucleotides, PRP, Profhilo, exosomes, HIFU-stimulated collagen remodelling, all work by recruiting the body's own biological repair processes.
They deliver a signal. The body responds to that signal by building new collagen, new elastin, new hyaluronic acid. But the quality and magnitude of that response depends entirely on the biological environment that receives the signal.
A fibroblast operating in a state of hormonal depletion, chronic inflammation, or nutritional deficiency produces less collagen in response to the same regenerative stimulus than a fibroblast operating in an optimised environment. The treatment is identical.
The outcome is not.
This is the clinical argument for a blood panel before any aesthetic treatment. And it is the argument that most of the aesthetics industry is not making, because most of the aesthetics industry is not asking the question.
What the biology actually needs to respond
Three Biological Systems That Determine Regenerative Response
System | What it controls | Why it matters for skin regeneration |
Hormonal system | Oestrogen, testosterone, DHEA, progesterone | Drives fibroblast activity, collagen synthesis, dermal thickness, wound healing |
Inflammatory system | CRP, cytokine balance, macrophage activity | Determines whether regeneration resolves into repair or chronic inflammation |
Nutritional system | Vitamin D, B12, zinc, protein, ferritin | Provides the raw materials required for collagen and tissue repair |
When you have a regenerative aesthetic treatment, you are not paying for a product to do something to your skin. You are paying for a stimulus that tells your own cells to do something. The product delivers the message. Your biology writes the reply.
That reply, the collagen your fibroblasts produce, the elastin your cells rebuild, the structural improvement that makes Profhilo or polynucleotides worth investing in, is determined by three biological systems working together.
The hormonal system. Oestrogen directly supports fibroblast function, collagen synthesis, and wound healing. A 2024 PMC narrative review confirmed that oestrogen enhances tissue repair by upregulating VEGF, stimulating angiogenesis, and playing a pivotal role in collagen regulation, the same growth factor pathways that regenerative aesthetic treatments are trying to stimulate.
Key Hormones and Their Skin Effects
Marker | Effect on skin biology | Low levels result in |
Oestradiol | Collagen synthesis, fibroblast activation, angiogenesis | Thinner skin, reduced elasticity, poor regenerative response |
Testosterone | Dermal thickness, fibroblast stimulation | Reduced structural support and skin density |
DHEA-S | Hormonal precursor for tissue repair pathways | Reduced regenerative capacity |
Progesterone | Tissue balance and repair modulation | Slower recovery and reduced resilience |
Testosterone contributes to dermal thickness and fibroblast activation through androgen receptors in the skin. When these hormones are declining, as they do progressively from the mid-30s onward and dramatically at menopause, the cellular machinery that regenerative treatments rely on is operating at reduced capacity. This does not make the treatments ineffective. It means they are working against a current that the blood panel can identify and, in many cases, address.
In cardiac nursing, we understood this principle from a different angle. The patients who recovered most effectively from cardiac intervention were not simply the ones who received the best procedure. They were the ones whose biology was in the best position to respond to it. Hormonal status, inflammatory burden, nutritional state: these determined recovery outcomes as much as surgical technique. I see the same dynamic in regenerative aesthetics every week.
In plain terms: the immune cell environment in your skin determines whether the inflammatory cascade triggered by a regenerative treatment resolves into productive tissue building or drags into prolonged low-grade inflammation that produces inferior results.
A patient with elevated CRP, an already-activated inflammatory state, or chronic metabolic dysfunction is starting the regenerative process from a disadvantaged position. The blood panel measures this directly.
The nutritional system. Collagen synthesis requires specific cofactors, vitamin C, vitamin D, zinc, and adequate dietary protein, without which the fibroblast cannot complete the structural building process that regenerative treatments initiate. Vitamin D deficiency, which affects one in five UK adults, directly impairs the immune modulation and cellular proliferation that regenerative treatments depend on.
B12 deficiency, widespread and under-diagnosed, compromises cell renewal across every tissue including the dermis. These are measurable deficiencies. They are correctable. And they are almost never assessed before a patient receives their first Profhilo course.
The research on biomarkers and aesthetic outcomes
The clinical literature is beginning to formalise what experienced practitioners have observed for years: your baseline biology predicts your treatment response.
Inflammatory and Metabolic Markers
Marker | What it indicates | Impact on regenerative treatments |
hs-CRP | Systemic inflammation level | High levels impair collagen formation and healing quality |
IL-1α / TNF-α | Pro-inflammatory cytokine activity | Promotes chronic inflammation instead of structured repair |
HbA1c | Long-term blood glucose control | Higher levels increase glycation of collagen and elastin |
Fasting glucose | Current metabolic state | Elevated levels reduce tissue repair efficiency |
A 2025 PMC paper on predictive biomarkers in aesthetic dermatology directly mapped specific blood and tissue biomarkers to aesthetic treatment outcomes. The findings are striking. Patients with elevated inflammatory biomarkers including CRP above 5 mg/L, elevated IL-1α or TNF-α, and persistent erythema were categorised as having heightened inflammatory tone that predicts delayed healing and suboptimal regenerative response, with the recommendation to de-escalate injection density and introduce anti-inflammatory intervention before proceeding. Patients with accelerated epigenetic skin ageing showed diminished regenerative potential and reduced collagen remodelling capacity.
In other words: the academic literature now has the evidence to say what longevity medicine practitioners have been saying clinically. You cannot fully predict or optimise a regenerative treatment outcome without knowing the biological environment you are treating into. This is not a niche academic position. It is increasingly the clinical consensus in evidence-based aesthetics.
What the blood panel tells you that nothing else does
The Advanced Blood Panel at Juvenology is designed around the markers most relevant to biological ageing and treatment response. Not the narrow range of a standard NHS blood test. Specifically the markers that predict how well your biology is positioned to respond to the treatments you are considering.
Hormonal markers
Oestradiol, testosterone, DHEA-S, SHBG, FSH, LH, and progesterone. These tell us where you are in the hormonal trajectory, whether the oestrogen and testosterone that support fibroblast function are at levels that allow meaningful regenerative response, or whether hormonal decline is the primary driver of the skin changes you are trying to address with treatment.
Thyroid function
TSH, free T3, free T4. Thyroid dysfunction is one of the most commonly missed drivers of skin quality change, dullness, poor texture, hair thinning, altered elasticity, and one of the markers most frequently absent from a standard GP test. A patient with subclinical hypothyroidism investing in a polynucleotide course is treating the skin symptom while the thyroid driver continues unchecked.
Inflammatory markers
High-sensitivity CRP, in combination with the hormonal and metabolic picture, tells us the systemic inflammatory burden your skin's regenerative capacity is working against. This is the inflammaging picture, the chronic low-grade inflammation that we have explored in depth on this blog as a primary driver of accelerated skin ageing.
Metabolic markers
HbA1c and fasting glucose. Glycation, the binding of sugar molecules to collagen and elastin, is now recognised as a significant driver of skin structural deterioration, and elevated HbA1c indicates that this process is active. A patient with persistently elevated blood sugar is glycating the collagen that regenerative treatments are trying to build. The blood panel catches this before treatment, not after it has underperformed.
Nutritional markers
Vitamin D, B12, ferritin, folate. These are the cofactors that allow cellular repair to proceed. They are correctable within weeks through supplementation or IV therapy. Identifying and addressing them before treatment changes outcomes measurably.
Cardiovascular markers
Full lipid profile, renal function, liver function. These are the markers that situate the patient's overall biological health and that carry implications for treatment safety as well as for long-term longevity planning beyond aesthetics.
Why most aesthetic clinics don't do this
The honest answer is that most aesthetic clinics are not structured to do this. Assessing blood panels, interpreting hormonal and metabolic markers, and translating them into clinical recommendations requires a longevity medicine background and medical registration. It also requires the time and the clinical framework to integrate the systemic picture with the aesthetic plan.
Most aesthetic clinics offer treatments. Juvenology offers a clinical approach that includes treatments. These are genuinely different propositions, and I say that not to position against other practitioners but because the distinction matters to the patients for whom the systemic picture is the missing piece.
This is not a criticism of the aesthetics industry. Many excellent practitioners are doing excellent work. It is an observation that the industry's standard model, consultation, treatment, results, is missing a step that meaningfully changes outcomes for the patients who need it most. The patients in perimenopause. The patients with unrecognised thyroid dysfunction. The patients whose skin is responding poorly to treatments that should be working.
The blood panel step is not a commercial upsell at Juvenology. It is the step that makes the clinical picture complete. For some patients, the results change the treatment recommendation entirely. For others, they confirm the plan is sound and allow us to proceed with confidence. For the patients who have been having aesthetic treatments without satisfactory results, they frequently explain exactly why.
Who specifically needs the blood panel before treatment
Every patient benefits from knowing their biological picture before making aesthetic investment decisions. But there are specific presentations where the blood panel is not just valuable. It is the most important first step.
Patients in perimenopause or post-menopause where oestrogen decline is the primary driver of the skin changes they want to address. As we covered in the perimenopause and skin post, the window of most rapid dermal collagen loss is the first five years post-menopause. Understanding where a patient is in that trajectory changes the treatment plan significantly.
Patient group | Why the blood panel is essential |
Perimenopausal / post-menopausal patients | Identifies oestrogen decline as primary driver of collagen loss and skin ageing |
Poor responders to regenerative treatments | Reveals hormonal, inflammatory, or metabolic reasons for weak results |
Hair thinning + skin ageing | Detects combined hormonal and nutritional deficiencies (thyroid, ferritin, B12, oestrogen) |
Fatigue / weight changes + aesthetic concerns | Identifies systemic dysfunction affecting skin response |
Men on TRT | Required for safe monitoring and optimisation of hormone therapy |
Longevity medicine patients | Establishes baseline biological ageing and treatment planning framework |
Patients whose previous regenerative treatments have underperformed. If polynucleotides, Profhilo, or PRP have produced less than expected results, the biological explanation is almost always in the blood panel. This is the clinical investigation that should follow disappointing treatment response, not a different product or a higher volume.
Patients with hair thinning alongside skin changes.
The combination is a classic hormonal and nutritional picture, oestrogen, testosterone, thyroid, ferritin, and B12 are the markers to examine, and they are all in the panel.
Patients with fatigue, weight changes, or other systemic symptoms alongside cosmetic concerns. These are signals that the systemic picture needs to be understood before the surface concerns are addressed. Treating the skin without addressing the driver is, as I often put it in consultation, trying to fill a bath with the plug out.
Men on TRT, for whom the blood panel is a clinical monitoring requirement, not an optional add-on.
Patients beginning a longevity medicine programme at Juvenology. The blood panel is the foundation from which every element of the longevity medicine approach is built.
What happens after the panel
The blood panel at Juvenology is not a one-way information transfer. It is the beginning of a clinical conversation.
Every panel is followed by a results consultation with me personally. Not a summary letter with ranges highlighted. A clinical appointment where the results are explained in plain English, contextualised against how you feel and what you are trying to achieve, and translated into clear, actionable recommendations.
Stage | What happens | Clinical purpose |
1. Blood analysis | Full hormonal, metabolic, inflammatory, and nutritional assessment | Establish biological baseline |
2. Results consultation | One-to-one clinical review in plain English | Translate biomarkers into meaning |
3. Clinical interpretation | Link biology to symptoms and aesthetic goals | Identify root causes |
4. Intervention planning | Lifestyle, nutritional, hormonal or medical recommendations | Optimise biological environment |
5. Treatment sequencing | Decide timing of aesthetic treatments | Ensure best regenerative response |
6. Regenerative phase | Profhilo, PRP, polynucleotides, etc. | Deliver treatment into optimised biology |
For some patients, those recommendations are purely lifestyle and nutritional: vitamin D supplementation, dietary protein adjustment, stress management that addresses the cortisol picture. For some patients, they involve a conversation about whether HRT, BHRT, or hormonal optimisation through our longevity medicine service is appropriate. For some patients, they change the aesthetic treatment plan entirely, sequencing the biological optimisation first, then the regenerative treatment into an environment that is positioned to respond.
For almost every patient, they provide a level of clinical understanding of their own biology that they have not had before. That understanding, independent of any treatment decision, is something patients consistently tell me is one of the most valuable things they have experienced in years of engaging with their health.
I have reviewed results with patients who have been having aesthetic treatments for a decade without a blood panel ever being mentioned. When we look at the results together, the explanation for why their treatments have been underperforming, the oestrogen depletion, the subclinical thyroid, the vitamin D at 22, is usually right there. The biology was never a mystery. It just wasn't being looked at. That is the most important thing the blood panel changes. Not the treatment. The picture.
If you are in Kent and want to understand what your biology is doing before making any aesthetic treatment decision, book your Advanced Blood Panel at Juvenology.
We see patients from across Kent including Maidstone, Tonbridge, Sevenoaks, Kings Hill, West Malling, Medway, and Chatham.
About the author
Nurse Marina is the founder of Juvenology Clinic in Maidstone, Kent, 35 minutes from Central London by train. She sees patients from across London and the South East who want a longevity medicine approach to aesthetic care that most London clinics are not offering.
She spent 25 years in nursing, including six years as a cardiac nurse at KIMS Hospital, before founding Juvenology to combine regenerative aesthetic medicine with longevity science.
She holds an Executive MSc in Longevity from the Geneva College of Longevity Science, has completed the Healthy Longevity Clinician Programme at the National University of Singapore, and holds qualifications in hormonal health from the Marion Gluck Academy.
She is NMC Registered, JCCP Verified, BACN Member, ACE Group Registered, a Member of the Royal College of Nursing, and recognised by the Professional Standards Authority.
Clinical references
Impact of Sex Hormones on Postoperative Outcomes in Plastic Surgery: Oestrogen, VEGF, Collagen Regulation — PMC, 2024 ncbi.nlm.nih.gov/pmc/articles/PMC12410364
Predictive Biomarkers: A New Frontier in Bespoke Aesthetic Dermatology — PMC, 2025 ncbi.nlm.nih.gov/pmc/articles/PMC12696351
Regeneration in Aesthetic Medicine: Mechanisms, Evidence, and Clinical Boundaries — PMC, 2025 ncbi.nlm.nih.gov/pmc/articles/PMC12828453
Inflammatory Signatures and Biological Markers in PRP Therapy: Macrophage Polarisation and Regenerative Outcomes — PMC, 2025 ncbi.nlm.nih.gov/pmc/articles/PMC12071426